AAD Issues Pediatric Atopic Dermatitis Guidelines - Top-Institutions - MDSpire

AAD Issues Pediatric Atopic Dermatitis Guidelines

Two companion guidelines provide 41 evidence-based recommendations on treatment and prevention, along with 29 statements on comorbidity associations in patients under 18

  • By

  • Kerri Miller

  • April 8, 2026

  • 6 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Immunology
    • Pediatric Dermatology
    • Atopic Dermatitis Research

  • #2

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, PA

    Key Differentiators

    • Pediatric Dermatology
    • Clinical Trials
    • Atopic Dermatitis

  • #3

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Dermatology
    • Pediatric Dermatology
    • Translational Research

  • #4

    Massachusetts General Hospital (MGH) Dermatology
    Massachusetts General Hospital (MGH) Dermatology

    Boston, MA

    Key Differentiators

    • Dermatology
    • Pediatric Dermatology
    • Clinical Research

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Pediatric Dermatology
    • Clinical Trials
    • Atopic Dermatitis

Original Source(s)

AAD Issues Pediatric Atopic Dermatitis Guidelines

  • by Kerri Miller

  • April 8, 2026

Related Content

Top 10 Evidence-Based Essentials in Dermatology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice

Atopic Dermatitis Treatment Targets Defined

Consensus definitions for disease control in atopic dermatitis aim to standardize clinical trial end points and support treat-to-target strategies.

Extracellular vesicles in atopic dermatitis: unraveling pathogenic mediators and engineering therapeutic vectors